Literature DB >> 6304986

Recovery of feline leukaemia virus from non-viraemic cats.

B R Madewell, O Jarrett.   

Abstract

The persistence of virus in the bone marrow of cats which had ostensibly recovered from feline leukaemia virus (FeLV) infection was investigated. Nineteen cats were exposed to FeLV by natural, contact infection and 36 weeks later three were found to be persistently viraemic while the remainder were non-viraemic and had virus neutralising serum antibodies. Virus was isolated in bone marrow cultures established from nine of the 16 non-viraemic cats which were considered, therefore, to have latent infections. Cats infected soon after exposure to FeLV carrier cats were more likely to become persistently viraemic or develop a latent infection than those infected later, which tended to recover. There was no difference in serum antibody levels between the latently infected and recovered cats. Whether cats with latent infections spread virus or develop FeLV-negative haemopoietic tumours was considered. Six kittens housed together for eight months with a cat with a latent infection showed no signs of having been exposed to FeLV. Virus was not isolated from bone marrow cultures of two cats with FeLV-free lymphosarcoma or myelomonocytic leukaemia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304986     DOI: 10.1136/vr.112.15.339

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  17 in total

1.  Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors.

Authors:  L Hanlon; D Argyle; D Bain; L Nicolson; S Dunham; M C Golder; M McDonald; C McGillivray; O Jarrett; J C Neil; D E Onions
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  A feline large granular lymphoma and its derived cell line.

Authors:  C M Cheney; J L Rojko; G J Kociba; M L Wellman; S P Di Bartola; L J Rezanka; L Forman; L E Mathes
Journal:  In Vitro Cell Dev Biol       Date:  1990-05

3.  Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets.

Authors:  R Hofmann-Lehmann; E Holznagel; P Ossent; H Lutz
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

4.  Feline leukemia virus immunity induced by whole inactivated virus vaccination.

Authors:  Andrea N Torres; Kevin P O'Halloran; Laurie J Larson; Ronald D Schultz; Edward A Hoover
Journal:  Vet Immunol Immunopathol       Date:  2009-10-31       Impact factor: 2.046

5.  Dominance of highly divergent feline leukemia virus A progeny variants in a cat with recurrent viremia and fatal lymphoma.

Authors:  A Katrin Helfer-Hungerbuehler; Valentino Cattori; Felicitas S Boretti; Pete Ossent; Paula Grest; Manfred Reinacher; Manfred Henrich; Eva Bauer; Kim Bauer-Pham; Eva Niederer; Edgar Holznagel; Hans Lutz; Regina Hofmann-Lehmann
Journal:  Retrovirology       Date:  2010-02-19       Impact factor: 4.602

6.  Molecular detection, phylogenetic analysis, and identification of transcription motifs in feline leukemia virus from naturally infected cats in malaysia.

Authors:  Faruku Bande; Siti Suri Arshad; Latiffah Hassan; Zunita Zakaria
Journal:  Vet Med Int       Date:  2014-11-17

7.  Retroviral DNA--the silent winner: blood transfusion containing latent feline leukemia provirus causes infection and disease in naïve recipient cats.

Authors:  Stefanie Nesina; A Katrin Helfer-Hungerbuehler; Barbara Riond; Felicitas S Boretti; Barbara Willi; Marina L Meli; Paula Grest; Regina Hofmann-Lehmann
Journal:  Retrovirology       Date:  2015-12-21       Impact factor: 4.602

8.  Rapid and sensitive insulated isothermal PCR for point-of-need feline leukaemia virus detection.

Authors:  Rebecca P Wilkes; Eman Anis; Dawn Dunbar; Pei-Yu A Lee; Yun-Long Tsai; Fu-Chun Lee; Hsiao-Fen G Chang; Hwa-Tang T Wang; Elizabeth M Graham
Journal:  J Feline Med Surg       Date:  2017-06-07       Impact factor: 2.015

Review 9.  Feline leukemia/sarcoma viruses and immunodeficiency.

Authors:  J Rojko; M Essex; Z Trainin
Journal:  Adv Vet Sci Comp Med       Date:  1988

10.  The receptor binding site of feline leukemia virus surface glycoprotein is distinct from the site involved in virus neutralization.

Authors:  I K Ramsey; N Spibey; O Jarrett
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.